Aripiprazole (Abilify) Does Not Cause Low DHEA-S
A borderline low DHEA-S level of 81.4 in a woman taking aripiprazole is not caused by the medication. There is no established mechanism or documented evidence linking aripiprazole to reduced DHEA-S production.
Why Aripiprazole Is Not the Culprit
Aripiprazole's mechanism of action involves partial agonism at dopamine D2 and serotonin 5-HT1A receptors, with antagonism at 5-HT2A receptors 1. The drug has no direct effects on the hypothalamic-pituitary-adrenal (HPA) axis or adrenal steroidogenesis pathways that would suppress DHEA-S production.
The FDA label for Abilify does not list any endocrine effects related to adrenal androgen suppression 1. While aripiprazole is associated with metabolic changes (weight gain, hyperglycemia, dyslipidemia) and hyperprolactinemia in some cases 2, 3, these effects do not involve DHEA-S suppression.
What Actually Causes Low DHEA-S
Low DHEA-S in women occurs through several mechanisms unrelated to antipsychotic medications:
- Age-related decline: DHEA-S naturally decreases with age, and levels can be low in some individuals without pathology 4
- Primary adrenal insufficiency: Would present with low cortisol, elevated ACTH, and multiple symptoms (fatigue, hypotension, salt craving) 5
- Chronic inflammatory conditions: Conditions like rheumatoid arthritis are associated with isolated low DHEA-S without other adrenal hormone abnormalities 6
- Hypopituitarism: Would affect multiple pituitary hormones, not just DHEA-S in isolation 7
Clinical Approach to Borderline Low DHEA-S
For a woman with DHEA-S of 81.4 on aripiprazole, evaluate for:
- Symptoms: Assess for persistent low libido, low energy, or depressive symptoms despite optimized psychiatric treatment 5, 4
- Other adrenal function: Check morning cortisol and ACTH to rule out adrenal insufficiency 5
- Age-appropriate reference ranges: DHEA-S levels decline significantly with age; verify the result is truly abnormal for her age 4
If symptomatic with confirmed low DHEA-S and normal cortisol/ACTH, consider a 6-month trial of DHEA replacement (25-50 mg daily) guided by morning DHEA-S levels, aiming for mid-normal range 5, 4. Discontinue if no sustained benefit after 6 months 5.
Common Pitfall
Do not attribute low DHEA-S to aripiprazole and discontinue effective psychiatric treatment. The medication is not the cause, and stopping it will not correct the DHEA-S level while potentially destabilizing the underlying psychiatric condition.